Nanotechnology and aptamers: applications in drug delivery
- 1 August 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 26 (8), 442-449
- https://doi.org/10.1016/j.tibtech.2008.04.006
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery PlatformAngewandte Chemie-International Edition, 2006
- Cell type–specific delivery of siRNAs with aptamer-siRNA chimerasNature Biotechnology, 2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF 165Proceedings of the National Academy of Sciences of the United States of America, 2005
- Targeted inhibition of αvβ3 integrin with an RNA aptamer impairs endothelial cell growth and survivalBiochemical and Biophysical Research Communications, 2005
- Automated RNA SelectionBiotechnology Progress, 1998
- Inhibition of Human Angiogenin by DNA Aptamers: Nuclear Colocalization of an Angiogenin−Inhibitor ComplexBiochemistry, 1998
- A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNABiochemistry, 1993
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990